James Rusche, PhD, Sr. Vice President, Research and Development, Repligen Corporation, discusses the work his company has done to identify development candidate for Friedreich's Ataxia.
Subscribe to:
Post Comments (Atom)
Popular Posts
-
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by mild to severe abdominal pain, discomfort, bloating and alter...
-
Cleft lip and cleft palate, which can also occur together as cleft lip and palate are variations of a type of clefting congenital deformity ... -
Cell membrane (also called the plasma membrane, plasmalemma, or "phospholipid bilayer") is a selectively permeable lipid bilayer f...
-
DNA extraction is a routine procedure to collect DNA for subsequent molecular or forensic analysis. There are three basic steps in a DNA ext...
-
The olfactory system is the sensory system used for olfaction. Most mammals and reptiles have two distinct parts to their olfactory system: ...
-
Lysogenic cycle, or lysogeny, is one of the two alternative life cycles of a virus inside a host cell, whereby the virus that has infected a... -
Dr. Marshall Orloff, UCSD Department of Surgery, discusses current surgical treatments for correcting morbid obesity in this presentation by...
No comments:
Write comments